new indications for glp-1 drugs Market Industry Trends and Global Forecasts The Clinical Application of GLP-1RAs

M., Brophy, S

1 The LEADER trial (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome ResultsA Long-Term Evaluation), a large double-blind, placebo-controlled trial, recently demonstrated that liraglutide added to standard therapy for a relatively short period of time (3.5-5 years) had a significant reduction in cardiovas-cular events and mortality compared to placebo in high-risk patients (hazard ratio [HR], 0.87

Relying on a global supply chain system and a digital trading platform, the company is committed to providing high-quality products and customized procurement solutions for overseas customers

Q: Does frequent IV dripping lead to permanent skin whitening